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Interleukin-2 (IL-2) is a small α-helical cytokine that regulates im-
mune cell homeostasis through its recruitment to a high-affinity
heterotrimeric receptor complex (IL-2Rα/IL-2Rβ/γc). IL-2 has been
shown to have therapeutic efficacy for immune diseases by pref-
erentially expanding distinct T cell compartments, and several regu-
latory T cell (Treg)-biasing anti–IL-2 antibodies have been developed
for combination therapies. The conformational plasticity of IL-2
plays an important role in its biological actions by modulating the
strength of receptor and drug interactions. Through an NMR anal-
ysis of milliseconds-timescale dynamics of free mouse IL-2 (mIL-2),
we identify a global transition to a sparse conformation which is
regulated by an α-helical capping “switch” at the loop between the
A and B helices (AB loop). Binding to either an anti-mouse IL-2
monoclonal antibody (mAb) or a small molecule inhibitor near the
loop induces a measurable response at the core of the structure,
while locking the switch to a single conformation through a designed
point mutation leads to a global quenching of core dynamics accom-
panied by a pronounced effect in mAb binding. By elucidating key
details of the long-range allosteric communication between the
receptor binding surfaces and the core of the IL-2 structure, our
results offer a direct blueprint for designing precision therapeutics
targeting a continuum of conformational states.
IL-2 | immunomodulation | protein dynamics | NMR | drug design
Interleukin-2 (IL-2) is a type I α-helical cytokine that functionsas a multilineage lymphocyte growth factor (1, 2). IL-2 signals
through a high-affinity (10 pM) heterotrimeric receptor complex,
consisting of the IL-2Rα (also called CD25), IL-2Rβ (CD122),
and γc (CD132) chains, and the intermediate-affinity (1 nM) het-
erodimeric receptor complex, consisting of the IL-2Rβ and γc chains
(Fig. 1A) (1–3). The IL2-Rα subunit is constitutively expressed in
high levels on regulatory T (Treg) cells and at lower levels on nat-
ural killer (NK) cells and resting effector CD8+ T cells, resulting in
differential IL-2 potency between different immune cell compart-
ments (4, 5). From a clinical perspective, both IL-2 agonism and
antagonism are of considerable importance, and it has been used for
more than three decades toward immunotherapies of malignancies.
The known plasticity of IL-2 has been an important parameter
in the generation of small molecules that bind to IL-2 and block
signaling (6, 7), engineering “superagonist” mutant versions of
IL-2 with high affinity for IL-2Rβ (8) and isolation of antibodies
that bind to IL-2, resulting in biasing its actions to different
immune cell subsets (9–11). Many efforts have partially focused
in to improve its therapeutic potential by manipulating its ability
to selectively target specific cell types (8, 11–16). In one approach,
monoclonal antibodies against IL-2 can alter its properties by
binding to a number of distinct conformational epitopes, thereby
modifying the interactions of IL-2 with any of the IL-2R subunits
resulting in the proliferation of either Treg or effector T (Teff) cells
(9, 10). For example, wild-type (WT) mouse IL-2 (mIL-2) can be
administered in complex with an anti-mouse IL-2 monoclonal
antibody (JES6-1) and used to preferentially induce Treg cell
proliferation (12). Subsequent work has validated therapeutic
applications of the JES6-1 immunocomplex, which promotes graft
tolerance (17, 18) and has shown efficacy in preclinical models of
diabetes (19, 20). Thus, the conformational states of IL-2 can be
selectively induced to achieve cell-type and receptor selectivity,
but more detailed insight is needed into the IL-2 conformational
transitions.
Focusing on mouse IL-2 as a model system, our team recently
determined the X-ray structure of the mIL-2/JES6-1 complex to
elucidate the mechanistic basis for its selective stimulation of
Treg over effector cells (10). JES6-1 sterically blocks interactions
with the IL-2Rβ and γc subunits, leading to a reduction of signaling
effects on IL-2RαLow effector cells. JES6-1 undergoes allosteric
exchange with the IL-2Rα subunit where surface-expressed
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IL-2Rα displaces the JES6-1 antibody and releases the cytokine
to signal through the high-affinity heterotrimeric receptor on
IL-2RαHigh Treg cells (Fig. 1B). Of particular relevance is the
mobility of the AB loop (the loop between α-helices A and B),
which has been shown to undergo a large conformational change
upon JES6-1 binding. The AB loop is the main binding site for
IL-2Rα, and crystallographic studies (10) demonstrated that key
residues in the IL-2 AB loop engage the JES6-1 antibody and the
IL-2Rα subunit in distinct orientations. Therefore, JES6-1 and
IL-2Rα binding are mutually exclusive, leading to bidirectional
exchange. Molecular dynamics simulations have suggested a
significant conformational rearrangement in the AB loop and
BC loop (the loop between α-helices B and C) characterizing the
transition from JES6-1–bound to IL-2Rα–bound states (15).
Despite the importance of IL-2 in T cell differentiation and
homeostasis, a detailed biophysical characterization of its dy-
namic properties remains elusive.
In the current work, we use methyl-based NMR spectroscopy
to establish that, in aqueous solution, free mIL-2 samples an
excited state corresponding to an autoinhibitory conformation
with distinct functional properties. Using a series of complemen-
tary NMR experiments, we characterize a cooperative transition,
which involves a concerted motion of an α-helical capping “switch,”
linking the AB loop with the hydrophobic core of the mIL-2 struc-
ture through a sequential repacking of core side chains. Global
quenching of core dynamics, through the introduction of a
designed point mutation at the switch region, leads to a three-
order-of-magnitude loss of affinity for the JES6-1 antibody and,
consistently, a loss of immunomodulatory activity in vitro. In-
sights derived from our data highlight the potential of targeting
specific IL-2 conformational states using mutagenesis or small-
molecule binders, to steer the conformational equilibrium toward
states with maximum effects on Treg cells for the treatment of au-
toimmune diseases, and on Teff cells for immunotherapy of cancer.
Results
Long-Range Effects on mIL-2 Core Dynamics upon Recognition of Its
Binding Partners. Due to their hydrophobic character, methyl
groups are well-suited NMR probes for monitoring the dynamics
of the structural core of proteins (21, 22). The chemical shifts of
methyl groups report on side chain rotameric states and local
magnetic environment, while their NMR measurement is less influ-
enced by the size of the system under investigation due to favorable
relaxation properties (23). To gain insight into conformational
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Fig. 1. A plastic mIL-2 core structure mediates recognition of its binding partners for immune modulation. (A) Schematic of IL-2 cytokine-receptor quaternary
complex formation. Assembly of the quaternary complex is thought to occur sequentially, with IL-2 first engaging IL-2Rα with a dissociation constant (Kd) of
∼10−8 M, which increases its affinity for the IL-2Rβ subunit, and finally recruiting the γc subunit to lock down the high-affinity quaternary complex (Kd of ∼10−11 M).
(B) Schematic of the proposed mechanism for mIL-2/JES6-1 immunocomplex-mediated selective proliferation of regulatory T (Treg) cells. The JES6-1 Ab (shown as
blue scFv) sterically blocks mIL-2 interaction with IL-2Rβ and γc subunits, preventing signaling of IL-2RαLow effector cells (right). However, an exchange
mechanism between JES6-1 and the IL-2Rα subunit allows a preferential release of mIL-2 for exclusive signaling on IL-2RαHigh Treg cells, biasing toward an
immunosuppressive response (left). (C) Overlay of 1H,13C-HMQC spectra of selectively labeled mIL-2 at the Iδ1-13CH3, L, V proS methyl positions, recorded in
the free (black) or as a stoichiometric complex with JES6-1 scFv (cyan) or IL-2Rα receptor (magenta), acquired at 800 MHz, 25 °C. The arrows highlight major
chemical shift effects. Selected methyl assignments are noted. (D) Mapping of methyl chemical shift changes on the crystal structure of mIL-2/JES6-1 complex
(PDB ID 4YQX) and (E) on the overlaid IL-2Rα subunit from the homologous hIL-2 quaternary complex structure (PDB ID 2B5I). The mIL-2 residues with CSPs >
0.05 ppm are shown with cyan spheres in the schematic representation of JES6-1–bound mIL-2 (blue) and with magenta spheres in IL-2Rα–bound mIL-2
(green).
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changes on mIL-2 induced by its binding partners, we prepared
selective 1H/13C MILV (Met, Ile, Leu and Val)-methyl labeled
samples on a uniform 12C, perdeuterated background. We obtained
NMR assignments of mIL-2 backbone and methyl groups using
a combination of transverse relaxation-optimized spectroscopy
(TROSY)-based triple-resonance and three-dimensional (3D)
out-and-back side chain transfer experiments. Under the condi-
tions of our NMR experiments, mIL-2 is strictly monomeric, as
characterized by size exclusion chromatography coupled to
multiangle laser light scattering (SEC-MALS) (SI Appendix, Fig.
S1). To obtain stereospecific resonance assignments of methyl
groups and to reduce spectral overlap observed in the free mIL-2
methyl spectrum, which is typical of α-helical proteins, we also
prepared a selectively Iδ1-13C1H3, proS L,V-13C1H3–labeled
protein sample (24). This approach allowed us to obtain un-
ambiguous side chain resonance assignments of Met e1, Ile δ1,
Leu δ1/δ2, and Val γ1/γ2 (60 methyl groups in total) (SI Appendix,
Fig. S1) (25), distributed throughout the structure, enabling us to
comprehensively map the cytokine’s surface and hydrophobic
core in the IL-2Rα and JES6-1–bound states (26, 27). Fig. 1C
shows 13C-1H band-selective optimized flip angle short tran-
sient (SOFAST) heteronuclear multiple quantum coherence
(HMQC) of I (LV)proS-methyl labeled mIL-2 unbound (Fig. 1C,
black) and as a stoichiometric complex with JES6-1 single-chain
Fv (scFv) (Fig. 1C, cyan) or IL-2Rα (Fig. 1C, magenta). The
weighted chemical shift perturbations (CSPs) are presented along
the mIL-2 sequence in SI Appendix, Fig. S2. In agreement with
previous surface plasmon resonance (SPR) measurements (10),
under our NMR sample conditions, mIL-2 forms tight complexes
with either JES6-1 or IL-2Rα. Exchange between the free and
bound states is slow on the chemical shift timescale, as shown by
detailed NMR titrations where we observe a unique set of peaks
corresponding to the free and bound states with large CSPs (up to
0.6 parts per million [ppm]) between them.
Notably, either receptor or antibody binding leads to mea-
surable conformational changes at the corresponding primary
binding sites (for example, L48δ2, L50δ2, and L54δ2 in the AB
loop) but also induces long-range effects at remote sites dis-
tributed throughout the structure, including L35δ2 and L38δ2 in
the A helix, L73δ2, L80δ2, and L86δ2 in the B helix, I101δ1 in the
C helix, and V129γ2, V130γ2, L133δ2, and I137δ1 in the D helix.
Mapping the most affected methyl groups on the mIL-2 structure
(Fig. 1 D and E) highlights a contiguous path connecting the AB
loop to the hydrophobic core of the structure. Overall, the
methyl CSPs reveal a global response of the mIL-2 structure,
indicative of allosteric communication between the primary
binding site at the AB loop and core residues of the cytokine (SI
Appendix, Fig. S2). Given that the four α-helical bundle core of
apo-IL-2 is maintained in the complexed forms with the IL-2Rα
receptor or JES6-1 antibody (backbone heavy atom rmsd of 0.8 Å
and 2.3 Å, respectively), our results suggest that binding of either
JES6-1 or IL-2Rα at the AB loop region induces a remodeling of
core side chains. Specifically, the observed methyl chemical shift
changes can arise from either changes in the lowest energy rotameric
state or through perturbations in ensembles of rotamers sampled
by the free and bound forms.
Free mIL-2 Samples a Global Transition to an Excited-State Conformation.
Based on our observation that the 1H-15N transverse relaxation-
optimized spectroscopy (TROSY) spectrum of free mIL-2 was of
marginal quality (SI Appendix, Fig. S1) with a significant fraction
of completely broadened amide resonances (33%), we hypoth-
esized that, in solution, mIL-2 undergoes exchange between
different conformational states. The loss of signal for amide
resonances corresponding to residues in the AB loop due to 15N
line broadening suggests that the loop is switching between
multiple backbone conformations with different chemical envi-
ronments on an intermediate (microseconds to milliseconds
[μs–ms]) timescale. This hypothesis is consistent with a recent
molecular dynamics (MD) simulation-based model in which free
IL-2 samples distinct conformations of the AB loop akin to the
crystallographically observed structures in complexes with the
JES6-1 antibody and IL-2Rα receptor (10, 15).
To characterize the conformational landscape sampled by free
mIL-2 in solution, we performed a series of 13C chemical ex-
change saturation transfer (CEST) (28) and 13C single-quantum
methyl Carr–Purcell–Meiboom–Gill (CPMG) relaxation disper-
sion experiments (29). Briefly, in CPMG experiments, the effec-
tive transverse relaxation rate (R2,eff) is measured as a function of
refocusing pulse frequency (νCPMG), which quenches the effects
of conformational exchange, producing so-called dispersion pro-
files. Such profiles can be fit to extract the rate of exchange between
the ground and excited conformational states, kex, the population of
the excited state, pE, and the chemical shift differences between the
two exchanging states jΔωj (ppm). In CEST, the intensities of
protein resonances are measured in the presence of a weak off-
resonance radiofrequency (B1) field, typically between 5 and 50 Hz,
where a series of two-dimensional (2D) experiments are acquired
with a varying offset of the B1 field. When the field offset coincides
with the resonance of an exchanging minor state, saturation transfer
occurs during a fixed period, leading to an attenuation of the res-
onance of the major state, which can be readily detected. This
enables the indirect observation of the resonance of the otherwise
“invisible,” minor state. While, in principle, both experiments can
be used to quantify conformational exchange processes in bio-
molecules (30), CEST is sensitive to motions ranging from ∼50
to 500 s−1 whereas CPMG on the order of 100 to 3,000 s−1. As a
result, CEST experiments are typically recorded at a reduced
temperature (4 to 10 °C), in order to slow the exchange to a
measurable regime.
Due to poor quality of the amide spectra of free mIL-2, we
turned to methyl spectra as a readout in both CPMG and CEST
experiments. Conformational exchange was observed for the
resonances of several methyl groups distributed throughout the
mIL-2 structure, as illustrated by representative residues on
the B helix (L80δ2), C helix (I101δ1), and D helix (L133δ1) (Fig.
2A). The resonances of 20 methyls exhibiting well-defined CPMG
dispersion curves (SI Appendix, Fig. S3A and Table S1) were used
in a quantitative analysis. The remaining mIL-2 resonances
exhibited low signal-to-noise (S/N) dispersion curves (at 18.8 T
magnetic field) or high spectral overlap. Dispersion curves were
fitted globally using a two-site exchange model, yielding a kex of
1,000 ± 72 s−1 and an excited state population of 8.0 ± 0.4% (SI
Appendix, Fig. S4). Additionally, 13C-CEST profiles for the same
residues (L80δ2, I101δ1, and L133δ1) revealed significant dips in
the 13C dimension, characteristic of an excited state (Fig. 2B and
SI Appendix, Fig. S5). To quantify the extent of structural adap-
tations upon formation of the excited state for each methyl site
participating in the exchange process, we extracted values of the
corresponding 13C chemical shift changes, jΔωj, from independent
fits of the CPMG relaxation dispersion and CEST datasets. We
observed good correlation between the resulting jΔωj values for
most methyl probes (Fig. 2C), suggesting that the two datasets are
likely reporting on a similar exchange process, with the caveat that
the CEST data were recorded at a lower temperature (10 °C
relative to the standard temperature of 25 °C used for CPMG data
acquisition). Thus, the two observed outliers in the data (L133δ1,
L80δ2) could arise from the temperature dependence of the
chemical shifts of the major and minor states.
Methyl groups exhibiting CPMG dispersion curves are plotted
on the homology-based model of free mIL-2 in Fig. 2D and
color-coded according to the magnitude of the fitted jΔωj values,
which report on differences in the local magnetic environment
between the major and minor conformations. Large jΔωj values
were observed for methyls at the AB loop (L48δ1, L54δ1), in
addition to the C terminus of the B helix facing toward the loop
De Paula et al. PNAS | March 31, 2020 | vol. 117 | no. 13 | 7185
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(L80δ2, V83γ1, L84δ1) and throughout the hydrophobic core of
the structure (I101δ1, V130γ2, L133δ1, and I137δ1). Thus, our
CPMG data suggest that free mIL-2 samples a global, cooperative
transition to an excited state, which involves a conformational
“switch” of the AB loop, coupled to a cooperative change affecting
the core methyl groups (Fig. 2E). Notably, a pronounced structural
change relative to the free form can be observed in the X-ray
structure of JES6-1–bound mIL-2 (10), in which the AB loop
(residues Y45 to T55) undergoes an ∼38° rigid-body rotation to
adopt a conformation that is optimal for interactions with the
antibody surface. Taken together, conformational plasticity of
the AB loop is a key component of the solution dynamics of free
mIL-2, relevant for the formation of a high-affinity immunomodulatory
complex.
To characterize the major conformation sampled by the AB
loop in solution, we analyzed methyl nuclear Overhauser effect
(NOE) intensities recorded in a 3D CM-CMHM SOFAST nuclear
Overhauser effect spectroscopy (NOESY) experiment (Fig. 2F),
relative to the corresponding distances observed in 1) a model of
free mIL-2 built using the human IL-2 apo-structure as a tem-
plate (Protein Data bank [PDB] ID code 1M47), 2) the cocrystal
structure of mIL-2 in complex with the JES6-1 antibody (Ab)
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Fig. 2. Solution dynamics and ground-state structure of free mIL-2 by methyl NMR. (A) Methyl-selective 13C single quantum CPMG relaxation dispersion
profiles carried out at two magnetic fields (600 MHz, purple; 800 MHz, blue) are shown for selected residues in the B helix (L80δ2), C helix (I101δ1), and D helix
(L133δ1) of WT free mIL-2. Experimental data are shown as small circles in all panels, with errors estimated from the S/N in the raw experimental data. The
best-fit lines are shown for a global analysis of 20 methyls with nonflat relaxation dispersion profiles using a two-site conformational exchange model. (B) 13C-
CEST profiles carried out at 800 MHz for L80δ2, I101δ1, and L133δ1. Plots of normalized intensity of the ground state resonance relative to a control experiment
where the saturating field is highly off-resonance (12 kHz), as a function of the position of the perturbing B1 field (with a measured strength of 16.2 Hz).
Uncertainties in the normalized intensity (I/Io) are determined from the root-mean-square deviation in the baseline of the raw CEST profiles where no intensity
dips are present (typically, n > 30). Global fits of the CEST data to a two-site model of chemical exchange are shown as solid red lines. The resonances of the major
state (gray solid lines) and fitted minor state (gray dashed lines) are indicated, with the resulting chemical shift difference shown in each plot. (C) Linear cor-
relation plot of chemical shifts of the excited state of WT mIL-2 obtained from 13C CPMG (x axis) and 13C CEST (y axis). CPMG and CEST experiments were
recorded at 25 °C and 10 °C, respectively. (D) Twenty methyl probes undergoing chemical exchange by CPMG are shown as spheres on the model structure of
mIL-2 and colored orange according to the magnitude of fitted jΔωj values. (E) Schematic representation of mIL-2 illustrating the interconversion between a
ground state, which is 92% populated, and an invisible, excited state, which is ∼8% populated. The doted arrows represent the coupled conformational
transition of the AB loop and the hydrophobic core of mIL-2. (F) 13CM-
1HM strips from a 3D CM-CMHM SOFAST NOESY experiment taken at the
13CM coordinates of
stereospecifically assigned methyl resonances noted on each panel, showing NOE cross-peaks between the methyl resonances of residues on the AB Loop. (G)
Close-up view of the AB loop region from a Rosetta homology-based model of free mIL-2 (using PDB ID 1M47 as a template) showing the network of observed
NOEs (black dotted lines), corresponding to the major (ground-state) solution conformation. The pattern of NOEs is consistent with a “closed” conformation of
free mIL-2, with where the AB loop is well-packed against the hydrophobic core of the structure.
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(PDB ID code 4YQX), and 3) a model of the mIL-2 build using
the human IL-2/IL-2Rα receptor complex structure as a tem-
plate (PDB ID code 2B5I). Consistently with the models of mIL-
2 in the apo and IL-2Rα receptor-bound states, we find that the
network of observed NOEs connecting the methyl groups of
M42, M53, L54, L80, V83, and V129 located at the vicinity of the
AB loop, (Fig. 2G, black dashed lines) is consistent with a
“closed,” well-packed conformation where the side chains of
M53 and L54 are making hydrophobic contacts with residues at
the hydrophobic core defined by the amphipathic A and B
α-helices. This is evident from the observation of several un-
ambiguously assigned short-range (5 Å upper limit) NOEs be-
tween the corresponding methyl groups (Fig. 2 D, F, and G). On
the contrary, in the antibody-bound mIL-2 structure, the AB
loop is found in an “open” conformation, with the methyl groups
of M53 and L54 oriented toward the solvent at distances from
the core methyls (13 Å), well beyond the NOE detection limit of
10 Å (Fig. 2G and SI Appendix, Table S2). Thus, our NOE data
provide strong evidence that the major state of free mIL-2 has a
closed AB loop conformation, similar to the X-ray structure of
human IL-2 in either the free form or in the complex with IL-2Rα.
A Conserved Hydrogen Bond Network Coupled to the Structural Core
Stabilizes the Excited mIL-2 Conformation. We next sought to
characterize the structural features of the excited-state confor-
mation identified by our CPMG and CEST experiments. Excited
states play important roles in protein function, including catalysis
(31–33) and complex formation via conformational selection or
induced fit-type mechanisms (34, 35). However, their de novo
structure modeling is challenged by the ambiguity in interpreting
methyl chemical shifts. A qualitative comparison of the placement
of residues undergoing conformational exchange in free mIL-2
(Fig. 2D) with those perturbed upon formation of the IL-2Rα–
and JES6-1–bound states (Fig. 1 D and E) showed a significant
overlap, both for residues that are within the AB loop and other
binding surfaces (L80δ2 and L86δ2) and also at the core of the
structure (L133δ2 and I137δ1), suggesting that the same sites that
participate in the formation of the excited state also undergo
structural changes upon formation of the mIL-2 tertiary complexes.
Our NOE-based analysis has shown that the backbone con-
formation of the AB loop in the major, “closed” state of mIL-2 is
inconsistent with the JES6-1–bound structure. Close inspection
of the structure reveals that, in the JES6-1 complex, the AB loop
instead participates in a network of C-capping interactions with
the A helix (Fig. 3 A and D). Specifically, the side chain guani-
dino group of R52 forms multiple hydrogen bonds with the
backbone carbonyl oxygens of M42, Y45 located at the C-
terminal end of A helix, and with R46, L48 at the N-terminal
part of the AB loop (Fig. 3 B and C). Conversely, in the free
structure of the homologous human IL-2 (PDB ID code 1M47,
termed “uncapped” state), the R52 side chain is solvent-exposed,
and M53 is buried at the hydrophobic interface between the A
and B helices. The “closed/uncapped” conformation is optimal
for interactions with coreceptors, as exemplified by the IL-2Rα
complex where R52 forms a salt bridge with a conserved aspartic
acid on the receptor surface (PDB ID code 2B5I). JES6-1 binding
therefore induces a transition from a “closed” to “open” AB loop
conformation, which exposes the hydrophobic side chains of L50,
M53, and L54 toward the surface of the molecule while the side
chain of R52 becomes buried. In this “capped” state, the loss of
hydrophobic packing contacts is compensated by the formation of
multiple C-capping hydrogen bonds with the A helix, and the
backbone of the loop itself (Fig. 3 A and C).
According to our NOE-based analysis, the placement of M53
at the hydrophobic interface between the AB loop and the core
of the structure promotes the “closed” loop conformation, which
is the major solution state. We sought to determine whether the
excited state sampled by free mIL-2 encompasses the C-capping
features of the “open” state. If the dynamics observed by NMR
correspond to a concerted process, such as an open-to-closed
transition of the AB loop, then mutations which destabilize the
open state should alter the observed exchange parameters in a
uniform manner. To perturb the “open” state conformation, we
used the mutant R52A, which eliminates all C-capping interac-
tions (Fig. 3C and SI Appendix, Fig. S6) (36), and compared the
resulting CPMG relaxation dispersion and CEST data performed
under identical conditions to our established results for the WT.
Remarkably, Ala mutation of R52 suppressed the CPMG re-
laxation dispersion profiles of all methyl probes that were un-
dergoing conformational exchange in theWT form (Fig. 3 E and F
and SI Appendix, Fig. S3B). Due to the significantly reduced dis-
persion range observed for methyl resonances of the R52A mIL-2
mutant, the χ2 surface obtained from a global fit of the CPMG
data does not show a well-defined minimum in terms of the es-
timated population and exchange rate, kex. Consistently, in CEST
profiles recorded using the R52A mutant, the second dip was
barely observed (I101δ1) or notably absent (L70δ2, I143δ1, L133δ1,
L133δ2) (Fig. 3 E and F and SI Appendix, Fig. S5), indicating that
the population of the excited state (“open” state) was below the
detection limits of the experiment. Both observations are con-
sistent with a significant “dampening” of μs–ms dynamics. The
R52A mutation quenched relaxation not only at the side chain
methyl but also the backbone amide groups, alleviating reso-
nance broadening and leading to a significant improvement in the
quality of the 1H-15N TROSY spectrum (SI Appendix, Fig. S6A).
These observations imply the presence of a global conformational
exchange process on the μs–ms timescale, involving a switching of
the AB loop coupled to a transient twisting or ‘‘breathing’’ of the
α-helices. Notably, the conserved C-capping sequence motif at the
AB loop is critical for the formation of the excited state.
To determine how destabilization of the excited state affects
mIL-2 binding to JES6-1, we used isothermal titration calorim-
etry (ITC) and measured the binding free energy (ΔG), and its
enthalpic (ΔH) and entropic (−TΔS) components both for WT
and R52A mIL-2 (Fig. 3 G and H). Consistently with previous
SPR measurements (10) and our observation of a tight complex
in slow exchange by NMR, WT mIL-2 binds JES6-1 with a high
affinity of 2 nM. The interaction is largely entropy-driven, with a
positive net enthalpy change of 12.7 kcal·mol−1 and a favorable
entropic contribution of −24.3 kcal·mol−1 at 293 K (Fig. 3H and
SI Appendix, Table S3). Notably, R52A binds to JES6-1 with
three orders of magnitude lower affinity than WT mIL-2, due to
less favorable binding entropy (Fig. 3 G and H). Given that the
side chain of R52 forms a salt bridge with E60 of JES6-1 in the
X-ray structure of the complex (Fig. 3A), the observed 1,000-fold
decrease in binding affinity reflects the combined effects of 1)
loss of binding enthalpy and 2) increase in free energy of the
“closed” state, which is competent for binding. Thus, our ITC
results show that perturbations of the capping hydrogen-bond
network coupled to global changes in core dynamics abrogate
JES6-1 binding by destabilizing the open conformation, consis-
tently with our NMR measurements showing a shift of the con-
formational equilibrium toward the closed state.
To determine the functional activity of the R52A mutant, we
probed JES6-1 antibody effects on mIL-2–induced signaling in
IL-2Rα+ subpopulations of mouse CTLL-2 cells as a surrogate for
its effects on IL-2Rαhi immune cell subsets (Fig. 3H). Consistent
with our NMR and ITC results, JES6-1 showed a fivefold reduced
WT mIL-2–mediated signal transducers and activators of tran-
scription 5 (STAT5) activation. However, STAT5 signaling po-
tency by R52A was independent of JES6-1, as demonstrated by
the comparable effective concentration, 50% (EC50) values, sug-
gesting that the weaker affinity to JES6-1 was primarily respon-
sible for the behavior of the R52A mutant (Fig. 3G).
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Allosteric Communication in mIL-2 through a Remodeling of Side
Chain Rotamers. Our methyl-based NMR probes revealed a global
response of the mIL-2 structure upon binding to JES6-1, alongside
the crystallographically observed conformational changes of the
AB loop (Fig. 1 C and D). Consistently, our NMR relaxation
measurements suggest a coupling of dynamic motions between
the loop and core methyls. We sought to identify a plausible
mechanism linking AB loop movement to changes in core side
chain packing during transitions between “closed/uncapped” and
“open/capped” conformations. To enumerate all possible side chain
rotamers that can be adopted by each residue, we performed a global
analysis of compatible rotamer pairs using a satisfiability-based
approach in Rosetta (Materials and Methods and SI Appendix, Fig.
S8) and mapped our results on the free and JES6-1–bound mIL-
2 structures (Fig. 4 and SI Appendix, Fig. S9). Using the backbone
conformations of the “open” and “closed” states as inputs, our
analysis highlights differences in rotamer sets that can be accessed
by the free (closed) and JES6-1 bound (open) states. We identi-
fied a large set of residues (L28, L39, M42, L48, M53, F58, F132,
L133, W136, and F139) (Fig. 4 A and B) spanning the AB loop, A
Helix and D Helix, and part of the hydrophobic core. For these
residues, the space of rotamers was significantly different between
the closed and open states, indicating a plausible remodeling of
packing interactions. Specifically, a 10-residue segment (V129 to
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Fig. 3. Effects of a conserved helical capping motif on IL-2 dynamics and function. (A) Crystal structure of mIL-2 (schematic) bound to JES6-1 (blue surface)
with a detailed view of the mIL-2/JES6-1 interface on the AB loop and B helix of the cytokine (PDB ID 4YQX). C-capping hydrogen bonds involving the R52 side
chain are shown as black lines. (B) The AB loop in mIL-2 adopts either an uncapped “closed” conformation (apo state) or a capped “open” conformation (JES6-
1–bound state). The open conformation is stabilized by an intramolecular C-capping interaction between the side chain of R52 and the backbone of M42-Y45-
R46. Black dashes indicate hydrogen bonds. The R52 side chain does not contribute to intramolecular stabilizing interactions in the closed conformation. Black
dashed arrow shows the direction of loop movement between the closed and open states. (C) Close-up view of the AB loop in the closed and open confor-
mations. The R52A mutation eliminates the C-capping interactions. (D) Sequence conservation pattern in the AB loop region in various IL-2 orthologs. (E)
Comparison of 13C-CPMG relaxation dispersion profiles for L80δ2, I101δ1, and L133δ1 of WTmIL-2 (purple) and R52A (green), at 600MHz and (F) 13C-CEST profiles
for WT mIL-2 (red) and R52A (green). Conformational exchange profiles throughput the mIL-2 structure are quenched by the R52A mutation. Experimental
errors in CPMG and CEST data are determined as described in Fig. 1. (G) Thermodynamic fingerprints of the interactions betweenWT and R52A mIL-2 with JES6-
1. Isothermal titration calorimetry thermographs and curve fits for titrations. The R52A mutation leads to a three-order-of-magnitude reduction in binding
affinity. To minimize enthalpy of solvation effects, all experiments were performed in 20 mM phosphate buffer, pH 7.2, 150 mM NaCl. Data shown are rep-
resentative of duplicate experiments. (H) STAT5 phosphorylation (pSTAT5) response to WT and R52A mIL-2 in the free state or JES6-1 immunocomplexes
treatment in IL-2Rα+ mouse CTLL-2 cells. R52A shows attenuated immunomodulation by the JES6-1 Ab while signaling via IL-2Rα+ is at similar levels to WT. μcal,
microcalorie; kcal, kilocalorie; MFI, median fluorescence intensity.
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F139) forming the hydrophobic face of the amphipathic D helix
exhibits expansions and contractions in allowed rotamer sets as
IL-2 transitions between the two states (SI Appendix, Fig. S8). A
concerted motion of the D helix upon binding of IL-2Rα has been
highlighted as having a functional role in the formation of the high-
affinity heterotrimeric signaling complex (37). These results are
consistent with our observed NMR chemical shift mapping of the
IL-2Rα and Ab-bound states (Fig. 1 C and D), suggesting that
the conformational transition between the free and complexed
states can lead to a redistribution of the rotameric states at the
hydrophobic core. A plausible allosteric communication network
starts at the AB loop on one end of the structure, traverses
through the inner core of mIL-2, and ends at the N terminus of
the A and D helices adjacent to the binding site of the IL-2Rβ
receptor (Fig. 4C). The hydrophobic core residues exhibiting
differences in rotamer sets also include sites with significant
chemical exchange contributions in our CPMG data, indicating
the presence of dynamics at the μs–ms timescale (Fig. 4C, orange
circles). Taken together, our results highlight a plausible allo-
steric communication network in the IL-2 structure mediated via
sequential remodeling of side chain packing interactions.
Skewing the Dynamic Landscape of mIL-2 by Ligand Binding. The
R52A mutation characterized here destabilizes the open mIL-2
conformation by perturbing the C-capping hydrogen-bond net-
work between the AB loop and B helix, leading to quenching of
conformational exchange throughout the core of the structure.
We hypothesized that a small molecule binding preferentially to
the closed AB loop conformation would impact the dynamic
landscape of mIL-2 in a similar manner. We used a known
compound targeting human IL-2 (hIL-2) (Ro 26-4550), to
compete with IL-2Rα binding (7, 38). The cocrystal structure
(PDB ID code 1M48) shows that Ro 26-4550 is nestled in a
hydrophobic pocket at the interface between the AB loop and B
helix, with the hIL-2 side chains of M39, V69, and L72 (mIL-2
residues M53, V83, and L86) packing against the terminal aro-
matic ring (7). We performed an NMR titration of increasing
molar ratios of Ro 26-4550 on isoleucine, leucine, and valine-
methyl–labeled WT mIL-2 using 1H-13C HMQC spectra as a
readout (Fig. 5A). Under our NMR conditions, we observed the
formation of a moderate-affinity (μM range dissociation constant
[Kd]) complex in fast exchange with the free mIL-2 form where
residues in close proximity to the AB loop (L48δ1, L54δ1, and
L60δ1) experience the largest effects (SI Appendix, Fig. S7).
However, CSPs extend beyond the AB loop, to sites in the hy-
drophobic core (L80δ1, V129γ2, V130γ2, L133δ2, and I137δ1) at
distances >12 Å from the inhibitor binding site in the cocrystal
structure (Fig. 5C). A quantitative NMR line shape analysis of
the resonances of V129γ2 and L133δ2 yielded an equilibrium
dissociation constant of 39.4 ± 5.5 μM (Fig. 5B), suggesting a
two-state cooperative transition impacting all sites in the ligand-
bound form. To further examine whether Ro 26-4550 binding
affects the μs–ms dynamics of mIL-2, we repeated 13C-CPMG
relaxation dispersion experiments, under saturation binding,
identical protein concentration and NMR sample conditions,
and compared with our established data recorded for the free
form (Fig. 5D). Our results indicate that Ro 26-4550 binding
strongly dampens relaxation of methyl groups that are un-
dergoing μs–ms conformational exchange throughout the mIL-2
structure. Thus, in agreement with our allosteric network model
of mIL-2, stabilization of the closed/uncapped conformation
through ligand binding reduces dynamic exchange at the hy-
drophobic core of mIL-2 as the conformational equilibrium is
skewed toward the closed state. The observation of residual ex-
change at the CPMG timescale suggests that sampling of the
open state is still permitted by the presence of the ligand.
Discussion
The unique conformational plasticity of IL-2 appears to play an
important role in targeting the IL-2 receptor signaling axis in
both agonist and antagonist mode. However, this plasticity also
presents an opportunity to target or otherwise manipulate the
conformational landscape of IL-2 for drug discovery, but more
detailed insights are needed for actionable value. Evidence for a
functional role of such conformational plasticity was provided in
previous studies focusing on both human and mouse IL-2. These
studies employed small molecule binding (6, 7), antibody engineering
(9, 12), or directed mutagenesis (8) to induce minor perturbations in
the cytokine’s core α-helical fold, leading to distinct immuno-
modulatory functions. Specifically, elucidating a link between
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specific allosteric effects on the IL-2 structure, induced by the
JES6-1 and S4B6 antibodies, with the targeting of opposing
immune cells types expressing different levels of receptor sub-
units in vivo has provided a solid foundation for immune
modulation through the stabilization of different IL-2 confor-
mational states. Conversely, the high-throughput screening of
hIL-2 libraries in yeast led to the identification of a variant,
termed “super-2,” comprising a helix that is locked in a confor-
mation which is primed for interactions with the IL-2Rβ subunit,
thereby leading to preferential expansion of cells lacking IL-2Rα
(8). These results were leveraged to discover a human Treg-based
Ab, akin to JES6-1, of significant therapeutic potential (11). Thus,
given the sequence and structure conservation of the IL-2 fold
across species, the results established for the mouse IL-2 paradigm
directly relate to human IL-2, whose use as a multifaceted protein
therapeutic (Proleukin) has been hampered by an incomplete un-
derstanding of its precise functional properties. Therefore, a de-
tailed characterization of the relevant conformational states and
their dynamic interconversion process in solution would provide a
road map for drugging IL-2, through a range of approaches.
Our methyl-based NMR measurements from two comple-
mentary methodologies, CPMG and CEST, provide strong sup-
port that free mIL-2 is highly dynamic at the μs–ms timescale and
samples an excited state via a concerted conformational transi-
tion of the AB loop and core of the structure. Functionally rel-
evant excited states have been previously described for a range of
protein and nucleic acid systems (30) and are typically separated
by relatively low energy barriers from the ground state. The inherent
plasticity of the AB loop and allosteric cross-talk with the hydro-
phobic core suggested an avenue for biasing the conformational
equilibrium by perturbing key features present in the excited
state conformation. Based on our analysis of crystallographically
observed snapshots of IL-2, we hypothesized that the excited
state might share similar features with the JES6-1 antibody-
bound structure, with respect to a stabilizing C-capping motif,
and tested this hypothesis through a detailed dynamic, binding,
and functional characterization of a designed Ala mutant. In fact,
our data demonstrate that the structural basis for such functional
complexity may be surprisingly simple: The global dynamic motions
of mIL-2 are induced by a conserved C-capping hydrogen-bond
network that is connected to the core of the structure and can be
switched on and off by a single point mutation (Fig. 3). Taken to-
gether, out results show that the IL-2 energy landscape is highly
malleable and establish a paradigm for controlling IL-2 cyto-
kine activity through designed changes in protein dynamics.
Analysis of our NMR, ITC, and functional data in the context
of the available IL-2 cocrystal structures suggests a general
scheme for molecular recognition between IL-2 and its binding
partners (Fig. 6). According to this model, free mIL-2 exists in a
preequilibrium between closed (major form, 92%) and open
conformations (minor form, 8%), with the AB loop and the hy-
drophobic core engaged in a cooperative motion on the μs–ms
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timescale. In the closed/uncapped (productive) state, the AB loop
is in a conformation that is primed to interact with the IL2-Rα
receptor. Formation of a C-capping hydrogen network locks the
AB loop in an open (autoinhibited) state, in which the loop adopts
a conformation that is optimal for interactions with the JES6-1
antibody (Fig. 6, left). Disruption of the C-capping hydrogen bond
network by mutation or small molecule binding shifts the equi-
librium toward the closed state and induces global changes in core
dynamics which ultimately lead to a reduction in Ab binding by
three orders of magnitude (Fig. 6, right). While the “closed” and
“open” conformations mediate high-affinity complex formation
with the receptor and Ab, respectively, the binding process is likely
achieved via the formation of an initial encounter complex where
additional induced structural adaptations follow the selection of
preexisting conformational states. This model is consistent with
the majority of protein–ligand binding examples where both pro-
cesses contribute to complex formation (34).
A consequence of allosteric cross-talk in the IL-2 fold is that
the protein becomes globally sensitive to mutations. Point mu-
tations can induce long-range effects, which may explain the high
level of sequence conservation of IL-2 residues removed from
the primary receptor recognition sites. Further examples of such
long-range modulation are provided by engineered IL-2 agonists.
IL-2 superkine (also denoted as “super-2”) functions indepen-
dently of IL-2Rα and has enhanced binding to IL-2Rβ, despite
five of the six mutations being clustered on the BC loop and
within the C helix core, removed from the IL-2Rβ primary
binding site. Instead, a cluster of hydrophobic substitutions (F80,
V85, and V86) induce a subtle change in C helix orientation,
leading to an increased affinity for IL-2Rβ. Super-2 exerts a
more potent expansion of tumor-specific cytotoxic T cell pop-
ulations, and a reduced expansion of Treg cells (8). Moreover,
Super-2 can be used as a platform for additional mutations that
inhibit binding to the γc receptor and, consequently, hetero-
dimerization of IL-2Rβ and γc, thereby acting as a potent an-
tagonist (13). Conversely, to bypass allosteric effects present in
the IL-2 fold, a de novo design approach was used to generate a
mimetic of IL-2/IL-15 showing an α-helical fold with a well-
packed hydrophobic core, denoted Neoleukin-2/15 (Neo-2/15)
(16). This synthetic molecule retains the binding surfaces for
the IL-2Rβ/γc receptors while also alleviating the requirement of
IL-2Rα/IL-15Rα for formation of a productive signaling com-
plex. Neo-2/15 exhibited enhanced antitumor activity in mouse
models, was more stable, and lacked detectable immunogenicity
(16). These studies highlight the potential for modulating IL-2
function through different design approaches, showing varying
levels of responsiveness to regulatory molecules and conditions
at the vicinity of the membrane signaling complex.
In summary, our results highlight the role of conformational
plasticity at conserved features of the IL-2 fold, acting locally and
allosterically to form an “excited” state with discrete functional
properties. Our NMR-based characterization offers a window to
access otherwise hidden states of the energy landscape that can
be then exploited to fine-tune the affinity and selectivity for
different IL-2 binding partners toward engineering novel cyto-
kine functions. For example, our established allosteric coupling
between the receptor binding sites to the hydrophobic core of the
structure presents an opportunity to alter IL-2 function through
Fig. 6. Conformational “priming” of free mIL-2 drives high-affinity complex formation. A global conformational transition enables mIL-2 to sample two
distinct states that are recognized by IL2-Rα and JES6-1 via additional induced fit steps (black arrows). In the closed conformation, the polar face of the AB
loop including R52 is primed to interact with the IL2-Rα receptor. Formation of a C-capping hydrogen bond network by R52 locks the AB loop in an auto-
inhibitory, open conformation with high affinity for the JES6-1 Ab. As shown in Figs. 3 and 4, point mutations or binding of small molecules can shift the
equilibrium to favor the closed conformation, with measurable functional effects (right). Representative exchange parameters and excited-state populations
obtained from our NMR data for mIL-2 are indicated. The backbone of the mIL-2 is colored as in Figure 1. Black arrows indicate equilibrium between the free
and bound states. Dotted double arrows represent the coupled conformational transition of the AB loop and hydrophobic core of mIL-2. Gray arrows indicate
the conformational equilibrium, with the longer arrow pointing to the major state (closed conformation).
De Paula et al. PNAS | March 31, 2020 | vol. 117 | no. 13 | 7191
BI
O
PH
YS
IC
S
A
N
D
CO
M
PU
TA
TI
O
N
A
L
BI
O
LO
G
Y
the introduction of core mutations and induction of allosteric
effects without directly affecting the receptor/Ab binding surfaces.
Indeed, the allosteric pathway elucidated in detail here using
mouse IL-2 as a model system has been recently exploited for
human IL-2 to develop Treg-biased antibodies that appear to work
by a similar mechanism (11). Given that the IL-2 fold presents a
limited surface area with overlapping binding epitopes, our find-
ings have important practical utility from an engineering and
synthetic biology perspective.
Materials and Methods
Specific details about mIL-2 NMR sample preparation and stereospecific iso-
topic labeling, backbone and methyl resonance assignments, relaxation dis-
persion and 13C CEST experiments, SEC MALS and ITC experiments, side chain
rotamer analysis, and STAT5 signaling are outlined in detail in SI Appendix.
Data and Materials Availability. NMR assignments for the freeWTmIL-2, mIL-2
in complex with JES6-1 scFv antibody, mIL-2 in complex with IL-2Rα, and R52A
mIL-2 mutant have been deposited in the Biological Magnetic Resonance Data
Bank under accession numbers 27969, 27970, 27971, and 27974, respectively.
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